Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense Carboplatin and Paclitaxel Neoadjuvant Therapy in Breast Cancer
NCT02059876Phase 2Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2013
- Primary completion
- Dec 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in breast cancer, sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
carboplatinpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02059876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02059876.